Metraipolis › archive › dc_e88dc108ed65

Assessing the Influence of Proton Pump Inhibitors on Clinical Outcomes in Hormone Receptor-Positive Metastatic Breast Cancer Patients Receiving CDK4/6… — Europe PMC PMID:41303797

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41303797
DOI
10.3390/medicina61111960
License (as archived)
solo-consultazione
Archived
2026-11-08T22:09:46.257Z
SHA-256 of the archived text
f71012e1530d22180aff8d5569325ace9146812f7844a26ce3f916c8116e3ec0
Stable URL of this page
https://metraipolis.com/documento/dc_e88dc108ed65

How to cite

Assessing the Influence of Proton Pump Inhibitors on Clinical Outcomes in Hormone Receptor-Positive Metastatic Breast Cancer Patients Receiving CDK4/6… — Europe PMC PMID:41303797 — Europe PMC (en), https://europepmc.org/article/MED/41303797 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e88dc108ed65 (Metraipolis archive dc_e88dc108ed65, sha256 f71012e1530d22180aff8d5569325ace9146812f7844a26ce3f916c8116e3ec0)
BibTeX
@misc{dce88dc108ed65,
  title = {Assessing the Influence of Proton Pump Inhibitors on Clinical Outcomes in Hormone Receptor-Positive Metastatic Breast Cancer Patients Receiving CDK4/6… — Europe PMC PMID:41303797},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41303797},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e88dc108ed65; sha256 f71012e1530d22180aff8d5569325ace9146812f7844a26ce3f916c8116e3ec0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41303797. Agents can read the archived copy with the MCP tool read_document.